-
Intuitive Surgical Soars On Stellar Q1 Results: Analysts Boost Price Targets Amid Robust Procedure Growth
Wednesday, April 19, 2023 - 12:06pm | 619Shares of Intuitive Surgical, Inc. (NASDAQ: ISRG) surged in after-hours trading on Tuesday, following the release of the company’s upbeat results for the first quarter. RBC Capital Markets On Intuitive Surgical Analyst Shagun Singh maintained an Outperform rating, while raising the price...
-
Jefferies: Reaction In Mallinckrodt Shares To Praxair Competition Overblown
Friday, October 5, 2018 - 12:15pm | 542Competition from Praxair, Inc. (NYSE: PX) has rattled Mallinckrodt PLC (NYSE: MNK) investors, but Jefferies' bullish thesis remains intact. The Analyst Jeffries analyst Anthony Petrone reiterated a Buy on Mallinckrodt with a $35 price target. The Thesis Mallinckrodt shares...
-
UPDATE: Jefferies Initiates Coverage on Mallinckrodt on Unique Market Position
Tuesday, November 26, 2013 - 11:55am | 108In a report published Tuesday, Jefferies analyst Anthony Petrone initiated coverage on Mallinckrodt PLC (NYSE: MNK) with a Buy rating and $60.00 price target. In the report, Jefferies noted, “Mallinckrodt is uniquely positioned in a consolidating Specialty Pharma industry having three attractive...
-
UPDATE: Jefferies Initiates Coverage on Haemonetics as Stock is Still Dominating Blood Solutions
Tuesday, November 26, 2013 - 9:53am | 103In a report published Tuesday, Jefferies analyst Anthony Petrone initiated coverage on Haemonetics Corporation (NYSE: HAE) with a Buy rating and $48.00 price target. In the report, Jefferies noted, “Haemonetics is the only pure-play blood management solutions provider, an area of increasing focus...
-
Alcon, Inc.Acquires LenSx, Still In Negotiations With Novartis (ACL, NVS)
Wednesday, July 7, 2010 - 12:11pm | 176Alcon Inc. (NYSE: ACL) has signed an agreement to acquire LenSx Laser for $744 million. Alcon is a specialty company focused primarily on eye care; the company produces pharmaceuticals, surgical equipment, and consumer eye care products. Jefferies analysts Joshua Jennings and Anthony Petrone...
-
St. Jude Medical (STJ) Receives Department Of Justice Attention
Wednesday, May 5, 2010 - 2:03pm | 213Jefferies & Company analysts Peter J. Bye, Joshua Jennings and Anthony Petrone maintained their Buy rating for shares of St. Jude Medical, Inc. (NYSE: STJ), with a price target of $49 per share. The analysts said that the Department of Justice had given St. Jude Medical, Inc. a "civil...